BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 23443110)

  • 1. MiR-218 impairs tumor growth and increases chemo-sensitivity to cisplatin in cervical cancer.
    Li J; Ping Z; Ning H
    Int J Mol Sci; 2012 Nov; 13(12):16053-64. PubMed ID: 23443110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long Noncoding RNA GAS5, Which Acts as a Tumor Suppressor via microRNA 21, Regulates Cisplatin Resistance Expression in Cervical Cancer.
    Wen Q; Liu Y; Lyu H; Xu X; Wu Q; Liu N; Yin Q; Li J; Sheng X
    Int J Gynecol Cancer; 2017 Jul; 27(6):1096-1108. PubMed ID: 28472815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD.
    Chen Y; Ke G; Han D; Liang S; Yang G; Wu X
    Exp Cell Res; 2014 Jan; 320(1):12-20. PubMed ID: 24183997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-205 Promotes Apoptosis of Cervical Cancer Cells and Enhances Drug Sensitivity of Cisplatin by Inhibiting YAP1.
    Li X; Li Y; Han Y; Dong B; Liu D; Che L; Liu Y; Wang Y
    Cancer Biother Radiopharm; 2020 Jun; 35(5):338-344. PubMed ID: 32379984
    [No Abstract]   [Full Text] [Related]  

  • 5. Suppression of long noncoding RNA NCK1-AS1 increases chemosensitivity to cisplatin in cervical cancer.
    Zhang WY; Liu YJ; He Y; Chen P
    J Cell Physiol; 2019 Apr; 234(4):4302-4313. PubMed ID: 30221354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Period circadian regulator 2 suppresses drug resistance to cisplatin by PI3K/AKT pathway and improves chronochemotherapeutic efficacy in cervical cancer.
    Wang Z; Li F; He S; Zhao L; Wang F
    Gene; 2022 Jan; 809():146003. PubMed ID: 34648915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
    Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
    Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy-mediated miR-29b expression inhibits the invasion and angiogenesis of cervical cancer.
    Li Y; Zhang Z; Xiao Z; Lin Y; Luo T; Zhou Q; Zhang X
    Oncotarget; 2017 Feb; 8(9):14655-14665. PubMed ID: 28122338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer-Derived Exosomal miR-651 as a Diagnostic Marker Restrains Cisplatin Resistance and Directly Targets ATG3 for Cervical Cancer.
    Zhu X; Long L; Xiao H; He X
    Dis Markers; 2021; 2021():1544784. PubMed ID: 34567283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-144 reverses cisplatin resistance in cervical cancer via targeting LHX2.
    Shi F; Su J; Liu Z; Wang J; Wang T
    J Cell Biochem; 2019 Sep; 120(9):15018-15026. PubMed ID: 31017720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-1284 enhances sensitivity of cervical cancer cells to cisplatin via downregulating HMGB1.
    Chen J; Li G
    Biomed Pharmacother; 2018 Nov; 107():997-1003. PubMed ID: 30257412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR‑519d‑3p/HIF‑2α axis increases the chemosensitivity of human cervical cancer cells to cisplatin via inactivation of PI3K/AKT signaling.
    Jiang L; Shi S; Li F; Shi Q; Zhong T; Zhang H; Xia Y
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. microRNA-381 suppresses the growth and increases cisplatin sensitivity in non-small cell lung cancer cells through inhibition of nuclear factor-κB signaling.
    Huang RS; Zheng YL; Zhao J; Chun X
    Biomed Pharmacother; 2018 Feb; 98():538-544. PubMed ID: 29287202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-375 is upregulated in acquired paclitaxel resistance in cervical cancer.
    Shen Y; Wang P; Li Y; Ye F; Wang F; Wan X; Cheng X; Lu W; Xie X
    Br J Cancer; 2013 Jul; 109(1):92-9. PubMed ID: 23778521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the lncRNA ZFAS1 in cervical cancer and its correlation with prognosis and chemosensitivity.
    Feng LL; Shen FR; Zhou JH; Chen YG
    Gene; 2019 May; 696():105-112. PubMed ID: 30738960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poor expression of microRNA-135b results in the inhibition of cisplatin resistance and proliferation and induces the apoptosis of gastric cancer cells through MST1-mediated MAPK signaling pathway.
    Zhou J; Chen Q
    FASEB J; 2019 Mar; 33(3):3420-3436. PubMed ID: 30576232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA HOXA11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by Suppression of miR-214-3p Expression.
    Wang X; Li H; Shi J
    Biomed Res Int; 2019; 2019():8645153. PubMed ID: 31275988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth arrest-specific 5 attenuates cisplatin-induced apoptosis in cervical cancer by regulating STAT3 signaling via miR-21.
    Yao T; Lu R; Zhang J; Fang X; Fan L; Huang C; Lin R; Lin Z
    J Cell Physiol; 2019 Jun; 234(6):9605-9615. PubMed ID: 30352127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of p53 expression and apoptosis by vault RNA2-1-5p in cervical cancer cells.
    Kong L; Hao Q; Wang Y; Zhou P; Zou B; Zhang YX
    Oncotarget; 2015 Sep; 6(29):28371-88. PubMed ID: 26318295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osthole promotes the suppressive effects of cisplatin on NRF2 expression to prevent drug-resistant cervical cancer progression.
    Su J; Zhang F; Li X; Liu Z
    Biochem Biophys Res Commun; 2019 Jun; 514(2):510-517. PubMed ID: 31056260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.